OWLT

Owlet Inc. (OWLT) | Rumor.io

Owlet

OWLT

Attention (50-day avg)0%

Attention rank (50-day avg)#2,001

Bullish sentiment (50-day avg)73%

Price to earnings ratio-2.21

Market capitalization149.3M

Earnings per share-0.3

Dividend yield (TTM)—

Revenue (annual)105.7M

Net income (annual)-39.7M

Social

What share of all stock conversation is about OWLT?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% +0

Aug 12

The CEO's return has a positive effect on the stock price, with some speculating that it may be a precursor to a buyout offer.
The company's Q2 2026 earnings report shows record revenue and progress in its subscription model, driving positive sentiment and a buy rating from a report.
There is speculation about a potential short squeeze or acquisition, with some users discussing the stock's potential as a meme or target for short sellers.

Generated by AI

Sentiment

Of the messages about OWLT that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0%	25% +5	58.33% -19.31	83% +2.36
Bearish	100%	75% -5	41.67% +19.31	17% -2.36

Bullish· Aug 12

$OWLT is expected to report strong revenue growth, with guidance indicating $42m in 2H 2024 and a full year on track for $72m-$77m.
The company's recent Q2 results showed 58% revenue growth, improved margins, and positive adjusted EBITDA, leading to a stock price increase of +14%.
$OWLT is undervalued with a market cap of $50m at $5.50, and holding above this level for 3 months could lead to further price appreciation.

Bearish· Jun 20

The company's short interest is high, with barely covered shorts and a significant number of warrants outstanding.
The market is experiencing a "pump and dump" scenario, with a large number of shares being dumped, leading to potential dilution and a subsequent price drop.
The company's stock price is vulnerable to a drop below a key support level, with some analysts predicting a close below 30 cents.

Generated by AI

Topics

Of the messages about OWLT that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	0%	29.34%
Announcements	—	—	0%	27.84%
Analysts	—	—	100%	26.35%
Earnings	—	—	0%	15.27%
Controversies	—	—	0%	0.6%
Macro	—	—	0%	0.6%

Announcements· May 15

Owlet, Inc. (NYSE:OWLT) has received UK medical device certification, following the recent achievement of CE Mark certification, expanding its reach throughout the European market.
The company has announced a strategic partnership with Wheel, an industry leader in providing virtual patient-centric care, to launch a virtual telehealth services platform and increase access to medical-grade infant monitoring technology.
Owlet reports strong first quarter 2024 results, citing partnerships that will allow the company to reach a wider range of consumers and make its products more accessible to families in the region.

Controversies· Oct 4

Owlet, Inc. ($OWLT) received a Warning Letter from the FDA related to the marketing of its Owlet Smart Sock product in the US.
The FDA Warning Letter requests Owlet cease commercial distribution of the Smart Sock for uses in measuring blood oxygen saturation and pulse rate, and also requests changes to the product's marketing language.
The controversy has led to multiple investigations into potential securities fraud by law firms and investor alert groups, resulting in a significant decline in Owlet's stock price.

Generated by AI

Community

Of the messages about OWLT, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	77.78%	69.57%	11.54%
Newcomers	0%	22.22%	30.43%	88.46%

Regulars· Aug 11

Owlet, Inc. has delivered a record Q2 2026 with $33.9 million in revenue, up 30% YoY, driven by strong top-line growth and surging adoption of its Owlet360 subscription.
The company's updated full-year 2026 financial outlook reflects a one-time IEEPA tariff refund recognized in Q2 2026, with total revenue expected in the range of $118 to $122 million, gross margin of 53% to 55%, and adjusted EBITDA of $10.75 to $12.75 million.
Owlet's Q2 2026 financial highlights include a record gross margin of 64.4%, excluding the tariff refund impact, and a net loss of $0.6 million, excluding the tariff refund impact, compared to a net loss of $37.4 million in Q2 2025.

Newcomers· Mar 20

Owlet, Inc. reported a significant improvement in its operating health, with a 95% decrease in adjusted EBITDA loss in the fourth quarter of 2023 compared to the same period in 2022.
The company's gross margin increased to 47.1% in the fourth quarter of 2023, up 810 basis points from 33.7% in 2022, and revenues were approximately $21.0 million for the same quarter.
Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, expressed confidence in the company's fundamentals and vision for the future, citing strong momentum and growth in 2024 through commercialization of new medical devices.

Generated by AI

News

Owlet Looks Interesting Again (NYSE:OWLT)

9d agoSeeking Alpha

Owlet: The Business Is Growing, But The Stock Isn’t (NYSE:OWLT)

Owlet remains a Buy despite flat stock performance, supported by strong Q2 results and ongoing business evolution. Read more on OWLT stock here.

25d agoSeeking Alpha

Owlet: High Risk, High Reward In Medical Tech And Subscription (NYSE:OWLT)

1mo agoSeeking Alpha

Owlet shareholders approve incentive plan amendment and elect directors at annual meeting

1mo agoInvesting.com

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)

Tipranks Press Release.

1mo agotheglobeandmail.com

Owlet, Inc. Q2 2026 Earnings Call Summary

Moby summary of Owlet, Inc.'s Q2 2026 earnings call

1mo agoYahoo Finance

Also Discussed

Investors talking about OWLT also mention

#	Name	Attention
1	SBG - Sandbridge Acquisition Corporation	——
2	AHAC - Alpha Healthcare Acquisition Corp.	——
3	LTRY - Lottery.com Inc.	——
4	FVAM - 5:01 Acquisition Corp.	——
5	Li-Cycle Holdings Corp.LICY	0%0
6	Spring Valley Acquisition Corp. IIISVAC	0%0
7	NSTB - Northern Star Investment Corp. II	——
8	Aeye Inc. WarrantLIDRW	0%new
9	SFTW - Osprey Technology Acquisition Corp.	——
10	Health Sciences Acquisitions Corporation 2HSAQ	0%0

Owlet Inc.

Healthcare
Medical Devices

Owlet Inc. is a company dedicated to developing technology-driven solutions that enhance the lives of parents and their infants. Primarily focusing on health and wellness, Owlet creates innovative baby monitoring devices aimed at providing peace of mind through advanced analytics. One of its flagship products is the Owlet Smart Sock, which tracks an infant's heart rate and oxygen levels using pulse oximetry technology. This data helps parents ensure their child is sleeping safely by promptly alerting them to any abnormalities detected. Owlet Inc. operates within the consumer electronics sector, intersecting health technology and new parental care markets. Founded with a mission to offer smarter healthcare for babies, the company utilizes data science to transform traditional parenting tools into modern, connected solutions. With a growing presence in North America and a commitment to expanding its reach, Owlet continues to play a pivotal role in the evolution of digital health monitoring solutions for families worldwide.

Website

Location

2940 West Maple Loop Drive

Lehi, UT, 84048

United States

Social

What share of all stock conversation is about OWLT?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% +0

Aug 12

The CEO's return has a positive effect on the stock price, with some speculating that it may be a precursor to a buyout offer.
The company's Q2 2026 earnings report shows record revenue and progress in its subscription model, driving positive sentiment and a buy rating from a report.
There is speculation about a potential short squeeze or acquisition, with some users discussing the stock's potential as a meme or target for short sellers.

Generated by AI

Sentiment

Of the messages about OWLT that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0%	25% +5	58.33% -19.31	83% +2.36
Bearish	100%	75% -5	41.67% +19.31	17% -2.36

Bullish· Aug 12

$OWLT is expected to report strong revenue growth, with guidance indicating $42m in 2H 2024 and a full year on track for $72m-$77m.
The company's recent Q2 results showed 58% revenue growth, improved margins, and positive adjusted EBITDA, leading to a stock price increase of +14%.
$OWLT is undervalued with a market cap of $50m at $5.50, and holding above this level for 3 months could lead to further price appreciation.

Bearish· Jun 20

The company's short interest is high, with barely covered shorts and a significant number of warrants outstanding.
The market is experiencing a "pump and dump" scenario, with a large number of shares being dumped, leading to potential dilution and a subsequent price drop.
The company's stock price is vulnerable to a drop below a key support level, with some analysts predicting a close below 30 cents.

Generated by AI

Topics

Of the messages about OWLT that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	0%	29.34%
Announcements	—	—	0%	27.84%
Analysts	—	—	100%	26.35%
Earnings	—	—	0%	15.27%
Controversies	—	—	0%	0.6%
Macro	—	—	0%	0.6%

Announcements· May 15

Owlet, Inc. (NYSE:OWLT) has received UK medical device certification, following the recent achievement of CE Mark certification, expanding its reach throughout the European market.
The company has announced a strategic partnership with Wheel, an industry leader in providing virtual patient-centric care, to launch a virtual telehealth services platform and increase access to medical-grade infant monitoring technology.
Owlet reports strong first quarter 2024 results, citing partnerships that will allow the company to reach a wider range of consumers and make its products more accessible to families in the region.

Controversies· Oct 4

Owlet, Inc. ($OWLT) received a Warning Letter from the FDA related to the marketing of its Owlet Smart Sock product in the US.
The FDA Warning Letter requests Owlet cease commercial distribution of the Smart Sock for uses in measuring blood oxygen saturation and pulse rate, and also requests changes to the product's marketing language.
The controversy has led to multiple investigations into potential securities fraud by law firms and investor alert groups, resulting in a significant decline in Owlet's stock price.

Generated by AI

Community

Of the messages about OWLT, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	77.78%	69.57%	11.54%
Newcomers	0%	22.22%	30.43%	88.46%

Regulars· Aug 11

Owlet, Inc. has delivered a record Q2 2026 with $33.9 million in revenue, up 30% YoY, driven by strong top-line growth and surging adoption of its Owlet360 subscription.
The company's updated full-year 2026 financial outlook reflects a one-time IEEPA tariff refund recognized in Q2 2026, with total revenue expected in the range of $118 to $122 million, gross margin of 53% to 55%, and adjusted EBITDA of $10.75 to $12.75 million.
Owlet's Q2 2026 financial highlights include a record gross margin of 64.4%, excluding the tariff refund impact, and a net loss of $0.6 million, excluding the tariff refund impact, compared to a net loss of $37.4 million in Q2 2025.

Newcomers· Mar 20

Owlet, Inc. reported a significant improvement in its operating health, with a 95% decrease in adjusted EBITDA loss in the fourth quarter of 2023 compared to the same period in 2022.
The company's gross margin increased to 47.1% in the fourth quarter of 2023, up 810 basis points from 33.7% in 2022, and revenues were approximately $21.0 million for the same quarter.
Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, expressed confidence in the company's fundamentals and vision for the future, citing strong momentum and growth in 2024 through commercialization of new medical devices.

Generated by AI

Owlet

Social

Aug 12

Bullish· Aug 12

Bearish· Jun 20

Announcements· May 15

Controversies· Oct 4

Regulars· Aug 11

Newcomers· Mar 20

Owlet Looks Interesting Again (NYSE:OWLT)

Owlet: The Business Is Growing, But The Stock Isn’t (NYSE:OWLT)

Owlet: High Risk, High Reward In Medical Tech And Subscription (NYSE:OWLT)

Owlet shareholders approve incentive plan amendment and elect directors at annual meeting

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)

Owlet, Inc. Q2 2026 Earnings Call Summary

Also Discussed

Owlet Inc.

Company Information

Location

Owlet Looks Interesting Again (NYSE:OWLT)

Owlet: The Business Is Growing, But The Stock Isn’t (NYSE:OWLT)

Owlet: High Risk, High Reward In Medical Tech And Subscription (NYSE:OWLT)

Owlet shareholders approve incentive plan amendment and elect directors at annual meeting

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)

Owlet, Inc. Q2 2026 Earnings Call Summary

Also Discussed

Social

Aug 12

Bullish· Aug 12

Bearish· Jun 20

Announcements· May 15

Controversies· Oct 4

Regulars· Aug 11

Newcomers· Mar 20